EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.

@article{Shankar2008EGCGIG,
  title={EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.},
  author={Sharmila Shankar and Suthakar Ganapathy and Sunil R Hingorani and R. K Srivastava},
  journal={Frontiers in bioscience : a journal and virtual library},
  year={2008},
  volume={13},
  pages={
          440-52
        }
}
We have shown that epigallocatechin-3-gallate (EGCG), a polyphenolic compound from green tea, inhibits growth and induces apoptosis in human pancreatic cancer cells. However, the preclinical potential of EGCG in a suitable mouse model has not been examined. In this study, we examined the molecular mechanisms by which EGCG inhibited growth, invasion, metastasis and angiogenesis of human pancreatic cancer cells in a xenograft model system. EGCG inhibited viability, capillary tube formation and… Expand
(-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells.
TLDR
Interestingly, EGCG effectively inhibited invasion and migration of HeLa cells and modulated the expression of related genes (MMP-9 and TIMP-1) . Expand
Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
TLDR
The results suggested that EGCG was able to inhibit the proliferation of R CC cells, induce apoptosis and effectively suppressed the migration and invasion of RCC cells. Expand
Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
TLDR
The data suggest that EA can inhibit pancreatic cancer growth, angiogenesis and metastasis by suppressing Akt, Shh and Notch pathways, and suggest that the use of EA would be beneficial for the management of pancreaticcancer. Expand
Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2.
TLDR
The results indicated that EGCG inhibited OVCAR‑3 cell proliferation and migration, potentially mediated via the activation of p38 MAPK and downregulation of the protein expression of MMP2. Expand
Epigallocatechin ‐ 3 ‐ gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p 38 kinase and matrix metalloproteinase ‐ 2
Epigallocatechin-3-gallate (EGCG), a major catechin in green tea, has recently been reported to exhibit anticancer effects on a number of types of cancer cells in vitro; however, the molecularExpand
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells
TLDR
It is demonstrated for the first time that EGCG causes marked suppression of VM through inhibiting the twist/VE-cadherin/AKT pathway in human PCa PC-3 cells. Expand
Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
TLDR
EGCG inhibited growth by affecting the cell cycle and induced apoptosis in different HCC cells by downregulating PI3K/AKT activity, suggesting the potential of EGCG as an anticancer agent in the prevention or treatment of HCC. Expand
Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells.
TLDR
It is suggested that EGCG could reduce the invasion and cell growth of tumor cells, and such a characteristic may be of great value in developing a potential cancer therapy. Expand
SU5416 and EGCG Work Synergistically and Inhibit Angiogenic and Survival Factors and Induce Cell Cycle Arrest to Promote Apoptosis in Human Malignant Neuroblastoma SH-SY5Y and SK-N-BE2 Cells
TLDR
Combination of SU and EGCG effectively blocked angiogenic and survival pathways and modulated expression of cell cycle regulators and can be a promising therapeutic strategy for controlling the growth of human malignant neuroblastoma cells. Expand
EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
TLDR
EGCG suppresses the growth, invasion and migration of pancreatic cancer cells, and induces apoptosis by interfering with the STAT3 signaling pathway, and further enhanced the therapeutic potential of gemcitabine and CP690550 against pancreaticcancer. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 67 REFERENCES
Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
TLDR
The results suggest that EGCG induces growth arrest and apoptosis through multiple mechanisms, and can be used for pancreatic cancer prevention. Expand
A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
TLDR
EGCG can inhibit cervical cancer cell growth through induction of apoptosis and cell cycle arrest as well as regulation of gene expression in vitro, and likely provides an additional option for a new and potential drug approach for cervical cancer patients. Expand
Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells.
TLDR
It is observed that the antiproliferative action of EGCG on pancreatic carcinoma is mediated through programmed cell death or apoptosis as evident from nuclear condensation, caspase-3 activation and poly-ADP ribose polymerase (PARP) cleavage. Expand
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
TLDR
A role for AKT is established in modulating the direct action of p53 on the caspase-dependent mitochondrial death pathway and it is suggested that these important biological molecules interact at the level of the mitochondria to influence curcumin sensitivity. Expand
Mechanisms of cancer prevention by tea constituents.
TLDR
The possible relevance of each of the proposed mechanisms to human cancer prevention is discussed in light of current bioavailability data for tea polyphenols and the potential limitations of animal models of carcinogenesis. Expand
Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro.
TLDR
It is suggested that components from black and green tea extracts can modulate the expression of genes known to play a role in the carcinogenesis process and, therefore, may be potential agents for chemoprevention against pancreatic cancer. Expand
Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer.
TLDR
It is shown for the first time that angiogenic activity is increased in both chronic pancreatitis and pancreatic carcinoma, suggesting that antiangiogenesis might be a novel target for prevention or therapy in chronic pancreatic diseases. Expand
Angiogenesis and apoptosis.
  • J. Folkman
  • Biology, Medicine
  • Seminars in cancer biology
  • 2003
This review assembles the laboratory and clinical evidence that cytotoxic chemotherapy and antiangiogenic therapy are each dependent on endothelial cell apoptosis. During cytotoxic chemotherapy,Expand
Role of angiogenesis in tumor growth and metastasis.
TLDR
Preclinical studies have shown that endostatin effectively inhibits tumor growth and shrinks existing tumor blood vessels and therapy with endogenous inhibitors of angiogenesis, such asendostatin and angiostatin may reverse the angiogenic switch preventing growth of tumor vasculature. Expand
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
TLDR
Anti-angiogenic therapy approaches offer a new promising anti-cancer strategy and a remarkably diverse group of over 20 such drugs is currently undergoing evaluation in clinical trials. Expand
...
1
2
3
4
5
...